Retrospective Analysis for Long-Term Survivors in advanced non-small cell lung cancer

Retrospective Analysis for Long-Term Survivors in advanced non-small cell lung cancer - Retrospective Analysis for Long-Term Survivors in advanced non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006913

Enrollment

500

Registered

2011-12-20

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who diagnosed with advanced non-small cell lung cancer (NSCLC) and administered gefitinib until October 2010 2.Stage IIIB/IV at the time of diagnosis 3.Performance status (PS) 0-2 at the time of diagnosis 4.Patients who responded to gefitinib with PR or CR assessed in daily clinical practice

Exclusion criteria

Exclusion criteria: 1.patients with curative surgical operation 2.patients with curative radiation therapy

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactFumio Imamura

Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Respiratory Medicine

imamura-fu@mc.pref.osaka.jp06-6972-1181

Outcome results